ANAMBRA SHMB WARNS HEALTH INFORMATION OFFICERS OVER LATE REPORTS, REITERATES 7TH-DAY DEADLINE. (PHOTO). #PRESS RELEASE.

Image
 ANAMBRA SHMB WARNS HEALTH INFORMATION OFFICERS OVER LATE REPORTS, REITERATES 7TH-DAY DEADLINE By Ebele Egoh The Anambra State Hospital Management Board (SHMB) has urged Health Information Management Officers to ensure accurate medical records, timely data submission and strict protection of patients’ confidential information to strengthen healthcare delivery across the state. The Director of Medical Support Services of the Board, Mrs Nneka Uzor, gave the call during a meeting and training session for health information personnel held on Oct. 9 at the SHMB conference hall. Mrs Uzor stressed that maintaining complete medical records and safeguarding patients’ information are essential professional responsibilities, cautioning  the officers against disclosing sensitive health information to unauthorised persons and urged them to uphold the highest standards of confidentiality. Also speaking, the Head of Health Information Management at the Board, Mrs Ijeoma Onyeogulu, outlined k...

ASTRA-ZENECA FINDS NO EVIDENCE OF INCREASED BLOOD CLOTH RISK FROM VACCINE.{PHOTO}.

 


(Reuters) - AstraZeneca Plc on Sunday said it had conducted a review of people vaccinated with its COVID-19 vaccine which has shown no evidence of an increased risk of blood clots.

The review covered more than 17 million people vaccinated in the European Union and United Kingdom.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the statement said.

Authorities in Denmark, Norway and Iceland have suspended the use of the vaccine over clotting issues, while Austria stopped using a batch of AstraZeneca shots last week while investigating a death from coagulation disorders.

Ireland on Sunday temporarily suspended AstraZeneca’s COVID-19 vaccine “out of an abundance of caution”.

The drugmaker said additional testing has and is being conducted by the company and the European health authorities and none of the re-tests have shown cause for concern.

There are also no confirmed issues related to quality of any of its COVID-19 vaccine batches used across Europe and rest of the world, the company said.

Comments

Popular posts from this blog

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.